DAY 1: THURSDAY OCTOBER 1ST (CGCC)
Presentations include a 5-minute Q&A period.
| 6:45 – | Registration | |
| 7:00 – 8:00 | Breakfast Symposium | |
| 8:00 – 8:15 | Welcome to CGCC | Dr. Sharlene Gill (BC) |
| 8:15 – 9:00 | Keynote: RAS and BRAF Targeting in GI Cancers | Speaker: Dr. Scott Kopetz (USA) |
| 9:00 – 12:20 | Colorectal Cancer | Chair: Dr. Sharlene Gill (BC) |
| 9:00 – 9:20 | Treatment of dMMR Early Stage CRC | Speaker: Dr. Michael Raphael (ON) |
| 9:20 – 9:40 | RT Considerations/Updates in Neoadjuvant Rectal Ca | Speaker: Dr. Emma Dunne (BC) |
| 9:40 – 10:00 | Adjunctive Strategies in Early Stage CRC (ASA, exercise) | Speaker: Dr. JP Solar Vasconcelos (BC) |
| 10:00 – 10:20 | Panel Discussion | Panel Chair: Dr. Sharlene Gill (BC) Panellists: Dr. Emma Dunne (BC), Dr. JP Solar Vasconcelos (BC), Dr. Michael Raphael (ON) |
| 10:20 – 10:35 | Refreshment Break | |
| 10:35 – 10:55 | Strategies to Overcome Resistance to Immune Checkpoint Inhibition for pMMR Colorectal Cancer | Speaker: Dr. Eric Chen (ON) |
| 10:55 – 11:10 | Non-Surgical Options for Oligometastatic mCRC | Speaker: Dr. David Liu (BC) |
| 11:10 – 11:25 | Non-Surgical Options for Oligometastatic mCRC | Speaker: Dr. Sylvia Sze Wai Ng (ON) |
| 11:25 – 11:40 | CRS/HIPEC – When & Where Not to Consider in mCRC Peritoneal Carcinomatosis | Speaker: Dr. Anand Govindarajan (ON) |
| 11:40 – 12:00 | Evolving Landscape of Refractory mCRC | Speaker: Dr. Mustapha Tehfe (QC) |
| 12:00 – 12:20 | Panel Discussion | Panel Chair: Dr. Sharlene Gill (BC) Panellists: Dr. Anand Govindarajan (ON), Dr. Sylvia Sze Wai Ng (ON), Dr. Mustapha Tehfe (QC), Dr. David Liu (BC) & Dr. Eric Chen (ON) |
| 12:20 – 13:00 | Lunch | |
| 13:00 – 16:00 | EsophagoGastric Cancers | Chair: Dr. Elena Elimova (ON) |
| 13:00 – 13:30 | Updates in HER2 Directed Approaches in GEJ/GC | Speaker: Dr. Elena Elimova (ON) |
| 13:30 – 13:50 | Evolving Landscape of Neoadjuvant/Periop Early Stage GEJ/GC | Speaker: Dr. Lucy Ma (ON) |
| 13:50- 14:10 | Is There Still a Role for RT in Early Stage Esophagogastric Cancers? | Speaker: Dr. Jelena Lukovic (ON) |
| 14:10 – 14:30 | Targeted Approaches in HER2-Negative Advanced Esophagogastric Cancers | Speaker: Dr. Stephanie Snow (NS) |
| 14:30- 14:50 | Panel Discussion | Panel Chair: Dr. Elena Elimova (ON) Panellists: Dr. Lucy Ma (ON), Dr. Jelena Lukovic (ON) & Dr. Stephanie Snow (NS) |
| 14:50 – 15:10 | Refreshment Break | |
| 15:10 – 15:50 | Pancreatic Cancer | Chair: Dr. Rachel Goodwin (ON) |
| 15:10 – 15:25 | Update in Pancreatic Cancer | Speaker: Dr. Dan Renouf (BC) |
| 15:25 – 15:40 | Future Directions | Speaker: Dr. Jennifer Knox (ON) |
| 15:40 – 15:50 | Panel Discussion / Q&A | Panel Chair: Dr. Rachel Goodwin (ON) Panellists: Dr. Dan Renouf (BC) & Dr. Jennifer Knox (ON) |
| 15:50 – 16:00 | Closing Remarks | Dr. Sharlene Gill (BC) |
| 16:00 – 17:00 | CMHCC/CGCC Welcome Reception |
DAY 2: FRIDAY OCTOBER 2ND (CMHCC)
Presentations include a 5-minute Q&A period.
| 7:00 – | Registration | |
| 7:15 – 8:15 | Breakfast Symposium | |
| 8:15 – 8:20 | Welcome to CMHCC | Dr. Laura Dawson (ON) |
| 8:20- 9:00 | Keynote: ESMO HCC Guideline Updates | Speaker: Dr. Arndt Vogel (ON) |
| 9:00 – 10:30 | Early/Resectable Hepatobiliary Disease | Chairs: Dr. Pablo Serrano (ON) |
| 9:00 – 9:20 | Role of Radiation Therapy in Unresectable Cholangiocarcinoma | Speaker: Dr. Amanda Taggar (ON) |
| 9:20 – 9:40 | What’s New in IR Ablative Therapies (RFA< Microwave, histotripsy.) | Speaker: Dr. David Liu (BC) |
| 9:40 – 10:00 | Surgery in the Era of Emerging Liver-Directed Therapies | Speaker: |
| 10:00 – 10:30 | Panel Discussion on Early/Resectable Hepatobiliary Disease | Panel Chair: Dr. Pablo Serrano (ON) Panellists: Dr. Amanda Taggar (ON) & Dr. David Liu (BC) |
| 10:30 – 10:50 | Refreshment Break | |
| 10:50 – 12:20 | Intermediate/ Locally Advanced Hepatobiliary Session | Chairs: Dr. Laura Dawson (ON) & Dr. Rachel Goodwin (ON) |
| 10:50 – 11:10 | From Lesion to Logic: LI RADS Updates and Tumor Response After Locoregional Therapy | Speaker: Dr. Ania Kielar (ON) |
| 11:10 – 11:30 | Debate: TARE vs SBRT for HCC | Speakers: TARE – Dr. David Liu (BC) SBRT – Dr. Michael Yan (ON) |
| 11:30 – 11:50 | Evolving Role of Neoadjuvant Treatment in Intrahepatic Cholangiocarcinoma | Speaker: Dr. Erica Tsang (ON) |
| 11:50 – 12:20 | Panel Discussion on Intermediate/Locally Advanced Hepatobiliary Disease | Panel Chairs: Dr. Laura Dawson (ON) & Dr. Rachel Goodwin (ON) Panellists: Dr. Michael Yan (ON), Dr. Erica Tsang (ON) & Dr. David Liu (BC) |
| 12:20 – 13:30 | Lunch | |
| 13:30 – 13:50 | Special Session: AI in Liver Cancer | Speaker: Dr. Rob Grant (ON) |
| 13:50 – 15:20 | Metastatic Hepatobiliary Sessions | Chair: Dr. Brandon Meyers (ON) & Dr. Vincent Tam (AB) |
| 13:50 – 14:15 | RT HPB in Metastatic Setting: Oligometastases & Palliation | Speaker: Dr. Mitchell Liu (BC) |
| 14:15 – 14:35 | How to Choose Between the First-line Systemic Therapy Options for HCC | Speaker: Dr. Hatim Karachiwala (AB) |
| 14:35 – 15:20 | Panel Discussion on Metastatic Advanced Metastatic Hepatobiliary Disease | Panel Chairs: Dr. Brandon Meyers (ON) & Dr. Vincent Tam (AB) Panellists: Dr. Rob Grant (ON), Dr. Hatim Karachiwala (AB) & Dr. Mitchell Liu (BC) |
| 15:20 – 15:30 | Closing Remarks |